Dr. K. M. Parthasarathy

• MBBS
• MD (General Medicine)
• DM (Medical Oncology)

• Extensive training in the administration of novel anti-cancer drugs, including Antibody Drug Conjugates and Tyrosine Kinase Inhibitors.
• Specialised experience in managing chemotherapy-induced side effects and supportive care.

• Member of key oncological societies in India.
• Registered with the Medical Council of India (MCI).

• Lung Cancer (Non-Small Cell and Small Cell)
• Breast Cancer (including Male Breast Cancer)
• Gall Bladder Cancer
• Oesophagus Cancer
• Liver/Hepatocellular Cancer
• Genitourinary Malignancies
• Leukemia
• Lymphoma

• Medical Oncology
• Precision Oncology
• Palliative Oncology
• Geriatric Oncology

• Immunotherapy: Unleashing the body's immune system to fight cancer.
• Targeted Therapy: Using drugs like Tyrosine Kinase Inhibitors to target specific cancer genes.
• Antibody Drug Conjugates (ADCs): delivering chemotherapy agents directly to cancer cells.
• Chemotherapy Management: For both solid tumours and blood disorders.
• PICC Line Management: Expertise in central venous access for long-term chemotherapy.

Current & Past Hospital Affiliations
Current Affiliation:

• Senior Consultant & Clinical Lead, Department of Medical Oncology, Dharamshila Narayana Superspeciality Hospital, New Delhi.

Past Affiliations:

• Dr. Parthasarathy has a long-standing association with premier cancer institutes in India, having served in various capacities at tertiary care centres and cancer research hubs prior to his current leadership role.

Academic & Research Roles

• Active researcher with a focus on real-world evidence in oncology.
• Mentor to DNB residents and medical students.
• Key contributor to studies on cost-effective chemotherapy protocols in the Indian setting.

Key Achievements & Contributions

• Demonstrated the efficacy of FOLFOX as a second-line chemotherapy for Gall Bladder carcinoma in Indian patients.
• Documented rare cases such as Prolonged Response to Immunotherapy in Hepatocellular Carcinoma, contributing to global medical literature.
• Conducted significant research on the safety and tolerance of generic drugs, helping make cancer care more affordable.

National & International Awards

• Recognised for his extensive publications in peer-reviewed journals regarding rare cancer presentations and drug efficacy.
• Acknowledged for his contribution to the field of vascular access (PICC lines) in oncology settings.

Recognitions & Honors

• Regularly invited faculty at national oncology conferences.
• Honoured for his community outreach programs promoting cancer awareness and early detection.

Published Papers in Medical Journals

• Prolonged response to Tyrosine kinase inhibitors followed by Immunotherapy in metastatic hepatocellular Carcinoma – Journal of Cancer Research and Therapeutics (2023)
• Tolerance and efficacy of branded generic Pemetrexed maintenance in Indian patients of metastatic non-squamous non-small cell cancer – Indian Journal of Cancer (2019)
• Paraneoplastic palmar fasciitis and polyarthritis syndrome in a metastatic breast cancer patient – Indian Journal of Paediatric and Medical Oncology (2019)
• Efficacy and safety of FOLFOX as a second-line chemotherapy for patients with locally advanced and/or metastatic carcinoma of gall bladder – Indian Journal of Paediatric and Medical Oncology (2019)
• Metastatic dermatosis in breast carcinoma on adjuvant trastuzumab – Indian Journal of Dermatology (2018)
• Male breast cancer in India- series from a Cancer Research Centre – Indian Journal of Surgical Oncology (2015)
• Adenocarcinoma of cervical esophagus arising in the Barrett's esophagus – Indian Journal of Surgical Oncology (2015)
• Peripherally inserted central catheters: Our experience from a cancer research centre – Indian Journal of Surgical Oncology (2014)
• Abraxane-Paclitaxel with albumin carrier – Indian Journal of Clinical Practice (2006)
• Palonosetron-the new long acting antiemetic – Indian Journal of Clinical Practice (2005)

Notable Cases Handled

• Managed a complex case of metastatic Hepatocellular Carcinoma where the patient showed a prolonged response to a sequential treatment of Tyrosine Kinase Inhibitors and Nivolumab (Immunotherapy), significantly extending survival beyond standard expectations.
• Successfully treated numerous patients with metastatic Non-Small Cell Lung Cancer using maintenance Pemetrexed, ensuring high quality of life.

Patient Testimonials
"Dr. Parthasarathy is not just a doctor but a pillar of strength. When my father was diagnosed with Stage 4 Gall Bladder cancer, we were losing hope. Dr. Parthasarathy’s suggested FOLFOX protocol worked wonders. He is calm, explains everything clearly, and is truly a top oncologist in India." - Mr. R. Verma

"I visited Dr. K M Parthasarathy for my mother's immunotherapy treatment. His knowledge of the latest drugs is exceptional. He guided us through the costs and side effects very transparently. We are very happy with the care provided." - Mrs. S. Chatterjee

"Compassion defines Dr. Parthasarathy. He treated my brother for lymphoma. Despite the aggressive treatment, he ensured my brother was comfortable throughout. We are forever grateful to him and his team." - A. Khan

Patient-Centred Care
Dr. Parthasarathy’s philosophy rests on the belief that cancer treatment must be holistic. He focuses on "Quality of Life" as much as "Quantity of Life," ensuring that supportive care and pain management are integral parts of the treatment plan.

Technology & Innovation
He is a strong proponent of adopting the latest global standards in India. By integrating Antibody Drug Conjugates and Immunotherapy into his practice, he offers patients access to cutting-edge treatments that target cancer cells with high precision while sparing healthy tissues.

The cost of medical oncology treatments varies significantly based on the stage of cancer, the specific drugs used (generic vs. patent), and the duration of therapy.

Note: These are estimated costs. For appointment booking and to get a personalised cost estimate, you can connect with the Cancer Rounds team.

Language Support
The Cancer Rounds team ensures that language is never a barrier. We provide translation services to assist international patients during consultations with Dr. Parthasarathy.

Visa & Travel Assistance
Cancer Rounds assists with Medical Visa letters, flight itineraries, and comfortable accommodation options near the hospital to ensure a stress-free stay for patients and their attendants.

Pre-treatment Virtual Consultations
Patients from abroad can schedule a video consultation with Dr. Parthasarathy via Cancer Rounds to review reports and discuss potential treatment plans before flying to India.